BladderScan Eliminates Unnecessary Catheterizations, Decrease Urinary Tract Infections
Verathon is expanding their BladderScan bladder volume instrument product line and confirming their commitment to provide innovative and practical infection control solutions to acute care facilities.
Urinary catheter-related UTIs are estimated to total over 561,000 per year and account for over 40% of all nosocomial infections. According to a recent national study in the American Journal of Medicine, these UTIs, the most common hospital-acquired infection, cost the health care system between $424 million to $451 million annually.
BladderScan instruments, which help monitor post-operative urinary retention and evaluate common urological conditions, have been proven to reduce the rate of nosocomial UTIs by preventing unnecessary catheterizations.
Verathon's newest device, the BladderScan BVI 9400 portable ultrasound instrument, is noninvasive, easy to use and employs patent-pending NeuralHarmonics technology. NeuralHarmonics technology not only improves both speed and accuracy in bladder volume measurement, but it helps achieve previously unattainable differentiation of the bladder, urine and hypo-echogenic regions, such as the uterus, thereby reducing error and minimizing uncertainty in measurements of bladder function.
Verathon is announcing a new Small Child Mode for the BVI 9400 bladder volume instrument. Small Child Mode enables health care providers to measure bladder volume noninvasively on children weighing less than 60 pounds and standing less than 48 inches high with the same instrument used for adult patients.
"With the increasing interest in infection control within the Acute Care community, the enhanced BVI 9400 not only offers health care providers a noninvasive bladder volume instrument for use across all patient age groups; it also provides a powerful and practical tool in preventing UTIs," said Gerald McMorrow, CEO, Founder and Chairman of the Board of Verathon, Inc.
Under new 2008 regulations, Medicare will no longer reimburse hospitals for treatment of preventable nosocomial catheter-associated UTIs beginning in October, driving greater need for such bladder measurement tools in hospitals nationwide.